Research led by top stroke experts, including researchers at UPMC, has greatly expanded the number of patients receiving clot-removing surgery in Pittsburgh’s Allegheny General Hospital, UPMC Presbyterian and UPMC Mercy. Last week their work was endorsed at the highest level.
The delicate surgery that uses a stent device to snare blood clots in major arteries of the brain is credited with helping patients recover from their strokes with less disability and greater independence in their lives. In ischemic strokes, the most common type, it only takes minutes for brain cells to die when the blood supply is cut off.

Now giving some stroke patients more time to get the brain-preserving treatment is recommended by the American Heart Association/American Stroke Association. In the first change since 2013, the group Wednesday said patients can have up to 24 hours after a stroke to be considered eligible for the surgery.
The removal of clots in the large blood vessels in the brain is known as thrombectomy. First, stroke patients should be given the clot-dissolving drug alteplase within 3 to 4½ hours, according to the guidelines.
Since many people have a stroke without anyone else nearby or wake up in the morning with stroke symptoms, those patients often had been ineligible to receive the surgery. Previous studies found thrombectomy was helpful up to 6 hours after stroke symptoms appear.
“Now in stroke there are no time windows anymore,” said Tudor Jovin, director of the UPMC Stroke Institute. Now, he said, two recent randomized trials have shown patients’ chance of being helped by surgery depends on the proportion of brain tissue that is irreversibly damaged compared to the amount of tissue that is in danger of permanent damage.

Even with the new guidelines, it is still important for patients to be taken to a stroke center as soon as possible, he said.
“The earlier you are treated, the less stroke you have. The benefits of the later time window doesn’t mean we can take our time. The same urgency has to apply, regardless of the time limit.”
Dr. Jovin was co-leader of the randomized DAWN trial, which reported in May that patients selected using brain imaging and a scale that measures physical impairment — instead of time alone — could be helped. Eligible patients had a small area of dead brain tissue and a much larger area that was threatened by loss of blood supply but still alive.
About half of the patients, 48.6 percent, who had the clot removed by stent were doing well and were independent at three months afterward. Only 13 percent did well in the group that had clot-busting drugs alone. The number of deaths in both groups was similar.
Just last week the second randomized trial using brain imaging, from Stanford University, reported that the time to save brain function using the surgery can go up to 16 hours after the stroke.
The latest results, from the DEFUSE 3 trial, were reported by Gregory W. Albers, director of the Stanford Stroke Center. Brain imaging software developed by Stanford was used to select patients and found that the clot removal helped nearly half of the people who were treated after the 6-hour window closed.
Patients were checked three months later and 26 percent of patients who got the standard treatment had died; 16 percent had severe disability. Results for patients who had clot removal were dramatically better: 14 percent died and 8 percent had major disability.
“Now we are showing with these more sophisticated ways of assessing how much brain is dead, how much is at risk,” Dr. Jovin said. He said most people come to the UPMC stroke center within 6 hours, but more patients may be brought in as the new guidelines become better known.
He said he has a different opinion about the importance of sophisticated imaging, explaining the DAWN trial took a simpler approach, using less technology to determine the area of tissue at risk.
A CT scan of the brain and a CT angiogram of its blood vessels are the standard now, he said, and they’re fast. That’s important for the 90 percent of patients who arrive within 6 hours.
“Apart from the fact it’s not widely available, images are time-consuming and time is of the essence in acute stroke. The 0-to-6-hour time window is absolutely critical,” he said.
“Once you go into a later time window, you can afford less speed,” he said. “You’re dealing with patients who have the capacity to sustain brain viability.” The blood flow in the brains of some patients may explain why they experience a slower rate of stroke damage, he said.
Dr. Jovin said the “mismatch” of the dead and threatened areas of the brain can be assumed in the first 6 hours of a stroke, but that imaging after that time can confirm there is a large area that can be saved through surgery.
“Most stroke centers have already adopted these approaches for almost a year,” said Ashis H.Tayal, medical director of Allegheny Health Network’s Comprehensive Stroke Center. “At Allegheny General Hospital, based on the imaging, we will treat people who have had strokes sometimes up to 24 hours.”

Dr. Tayal said the CT scans that show blood flow, with pink and green marking dead and damaged brain tissue, might be able to be done at primary hospitals within AHN to see if patients would benefit from surgery at Allegheny General Hospital.
“The cost of equipment is small compared to how beneficial the treatment is to the patient, and how frequently they are used,” he said.
Dr. Jovin said the DAWN researchers would like to expand the stroke treatment beyond stroke centers, beyond the United States, Western Europe and other places where it is now available.
“In the rest of the world, people come to the hospital after 6 hours. Our biggest impact will be outside of our systems,” he said. “In developing countries, treatment of stroke is minimal. … The next step forward is to simplify things, to make this available and possible, so that sophisticated imaging does not have to be available.”
Jill Daly: jdaly@post-gazette.com or 412-263-1596.





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.